Not applicableStudy completedNCT01129479What this trial is testingGalantamine Treatment for Nonfluent Aphasia in Stroke PatientsWho this might be right forAphasiaStroke University of North Carolina, Chapel Hill 8
Post-approval studies (Phase 4)Study completedNCT00164242What this trial is testingTreatment of Tardive Dyskinesia With GalantamineWho this might be right forTardive Dyskinesia Caroff, Stanley N., M.D. 36
Testing effectiveness (Phase 2)WithdrawnNCT02246075What this trial is testingStudy of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving MemantineWho this might be right forAlzheimer's DiseaseDementiaCognition FORUM Pharmaceuticals Inc
Testing effectiveness (Phase 2)Ended earlyNCT01690195What this trial is testingSafety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease AbbVie (prior sponsor, Abbott) 343
Testing effectiveness (Phase 2)Study completedNCT00083590What this trial is testingHuperzine A in Alzheimer's DiseaseWho this might be right forAlzheimer Disease National Institute on Aging (NIA) 150
Post-approval studies (Phase 4)Study completedNCT01191918What this trial is testingThe Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute ManiaWho this might be right forBipolar DisorderMania Shanghai Mental Health Center 40
Large-scale testing (Phase 3)Study completedNCT02006654What this trial is testingStudy of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase InhibitorWho this might be right forAlzheimer's Disease H. Lundbeck A/S 734
Testing effectiveness (Phase 2)Ended earlyNCT00105105What this trial is testingMifepristone as Adjunctive Therapy in Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Corcept Therapeutics 160
Testing effectiveness (Phase 2)Temporarily pausedNCT03312244What this trial is testingPyridostigmine as Immunomodulator in People Living With HIVWho this might be right forHIV-1-infectionCD4+ T LymphocytopeniaImmune Deficiency+1 more Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 60
Large-scale testing (Phase 3)Study completedNCT02255799What this trial is testingMulticenter Evaluation of Memory Remediation After TBI With DonepezilWho this might be right forTraumatic Brain InjuryMemory Deficits Baylor College of Medicine 75
Not applicableStudy completedNCT00533065What this trial is testingEffects of Donepezil on Deficits Associated With Age-Related Decrease of Growth HormoneWho this might be right forElderly Ludwig Boltzmann Gesellschaft 80
Very early researchEnded earlyNCT03937908What this trial is testingPharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive ImpairmentWho this might be right forCognitive ImpairmentElderly Oregon Health and Science University 5
Not applicableStudy completedNCT00423228What this trial is testingEfficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's DiseaseWho this might be right forModerate Alzheimer's Disease Debiopharm International SA 228
Large-scale testing (Phase 3)Study completedNCT00191009What this trial is testingAdding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's DiseaseWho this might be right forAlzheimer Disease Eli Lilly and Company 124
Not applicableStudy completedNCT00954616What this trial is testingInappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the ElderlyWho this might be right forAlzheimer's Disease University Hospital, Limoges 636
Not applicableStudy completedNCT00748007What this trial is testingEfficacy of Rivastigmine in Patients With Down SyndromeWho this might be right forDown Syndrome National Taiwan University Hospital 14
Testing effectiveness (Phase 2)WithdrawnNCT01442766What this trial is testingDonepezil Trial for Motor Recovery in Acute StrokeWho this might be right forAcute Stroke Imperial College London
Post-approval studies (Phase 4)Ended earlyNCT00232349What this trial is testingEfficacy of Galantamine to Treat SchizophreniaWho this might be right forSchizophreniaPsychotic Disorder Seattle Institute for Biomedical and Clinical Research 21
Not applicableStudy completedNCT02007291What this trial is testingGood Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of TreatmentWho this might be right forLate Onset Alzheimer Federal University of Minas Gerais 71
Post-approval studies (Phase 4)Study completedNCT01951118What this trial is testingOlfactory Deficits and Donepezil Treatment in Cognitively Impaired ElderlyWho this might be right forAlzheimer DiseaseMild Cognitive ImpairmentDelirium, Dementia, Amnestic, Cognitive Disorders New York State Psychiatric Institute 121